Zoref-Shani E, Bromberg Y, Shirin C, Sidi Y, Sperling O
Department of Chemical Pathology, Sackler School of Medicine, Tel Aviv University, Israel.
J Mol Cell Cardiol. 1992 Feb;24(2):183-9. doi: 10.1016/0022-2828(92)93154-c.
The metabolic fate of labeled hypoxanthine and inosine, degradation products of adenine nucleotides, was studied in cultured beating cardiomyocytes, in order to assess the physiological significance of their contribution to salvage nucleotide synthesis in the heart. Inosine and hypoxanthine were found to be incorporated into nucleotides by a similar rate, but in the presence of 8-aminoguanosine, a potent inhibitor of purine nucleoside phosphorylase (EC 2.4.2.1), the rate of inosine incorporation into nucleotides was markedly reduced (by 75%), indicating that inosine incorporation to IMP (inosinic acid) occurs following its degradation to hypoxanthine. The proportion of hypoxanthine converted to IMP by hypoxanthine-guanine phosphoribosyltransferase (EC 2.4.2.8) is markedly greater than that degraded to xanthine and uric acid by xanthine oxidase (EC 1.3.2.3). However, close to 50% of the IMP formed was degraded to inosine by IMP 5'-nucleotidase (EC 3.1.3.5). The results demonstrate the activity of the following futile cycle in the cardiomyocytes: hypoxanthine----IMP----inosine----hypoxanthine. The rational for the activity of this energy consuming cycle is yet unclear.
为了评估腺嘌呤核苷酸的降解产物——标记次黄嘌呤和肌苷在心脏中对补救性核苷酸合成的贡献的生理意义,研究人员在培养的搏动心肌细胞中研究了它们的代谢命运。发现肌苷和次黄嘌呤以相似的速率掺入核苷酸,但在嘌呤核苷磷酸化酶(EC 2.4.2.1)的有效抑制剂8-氨基鸟苷存在下,肌苷掺入核苷酸的速率显著降低(降低75%),这表明肌苷在降解为次黄嘌呤后再掺入IMP(次黄苷酸)。次黄嘌呤通过次黄嘌呤-鸟嘌呤磷酸核糖转移酶(EC 2.4.2.8)转化为IMP的比例明显大于通过黄嘌呤氧化酶(EC 1.3.2.3)降解为黄嘌呤和尿酸的比例。然而,形成的IMP中近50%被IMP 5'-核苷酸酶(EC 3.1.3.5)降解为肌苷。结果证明了心肌细胞中存在以下无效循环:次黄嘌呤→IMP→肌苷→次黄嘌呤。这个耗能循环的活性原理尚不清楚。